Hemipelvectomy for Pelvic Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how different types of hemipelvectomy surgeries affect individuals with pelvic tumors over the long term. Researchers will assess the impact of these surgeries on daily function and quality of life by examining medical records, physical performance, and patient feedback. Individuals who have had or will undergo a hemipelvectomy (a surgery where part of the pelvis is removed) may be suitable for this study. Participants will undergo tests and complete questionnaires before surgery, a few weeks after, and regularly for up to ten years. As an unphased study, this trial offers a unique opportunity to contribute valuable insights that could enhance future surgical outcomes and quality of life for others.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Why are researchers excited about this trial?
Researchers are excited about this trial because it offers a comprehensive approach to understanding the long-term effects of hemipelvectomy on quality of life. Unlike standard treatments that focus solely on the surgical outcomes for pelvic tumors, this trial includes regular physical performance tests, quality-of-life assessments, and detailed questionnaires over a span of 10 years. This method aims to capture a holistic view of a patient's recovery journey, providing valuable insights into both physical and emotional well-being post-surgery. By tracking these aspects over time, researchers hope to improve post-operative care and support for patients undergoing this significant procedure.
Who Is on the Research Team?
Valerae O Lewis
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-surgery Assessment
Participants undergo physical performance assessments and complete quality of life assessments and questionnaires before hemipelvectomy
Post-surgery Assessment
Participants complete quality of life assessments and questionnaires at 6 weeks post-hemipelvectomy
Follow-up
Participants are monitored every 3 months up to 12 months and yearly thereafter for 10 years
What Are the Treatments Tested in This Trial?
Interventions
- Electronic Health Record Review
- Physical Performance Testing
- Quality-of-Life Assessment
- Questionnaire Administration
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients undergo physical performance assessments and complete quality of life assessments and questionnaires pre-hemipelvectomy, at 6 weeks post-hemipelvectomy, and then every 3 months up to 12 months and yearly thereafter for 10 years. Patients who are 1 year out from surgery complete pain-related questionnaires once. Patients who have already undergone hemipelvectomy prior to enrollment undergo medical record review.
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.